ArticlePLOS digital health2026
Validation is not enough: Longitudinal evidence of post-deployment fragility in clinical AI systems.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathogen prevalence, feature composition and cross-centre generalisability of machine learning diagnostic models for multi-pathogen respiratory infection.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pre-deployment validation is commonly used to establish the safety and effectiveness of clinical artificial intelligence systems, but acceptable validation performance does not guarantee stable behavior after deployment into routine clinical workflows. We conducted a longitudinal retrospective observational study of four clinically deployed AI systems operating across distinct clinical domains and workflows within a large healthcare organization. Using routinely collected clinical data, outcome labels, and operational telemetry, we compared validation-era performance with post-deployment behavior over extended observation periods. Analyses focused on temporal patterns of discrimination, calibration, data availability, latency, and workflow-related signals, with particular attention to label-dependent and label-independent monitoring. Across all systems, validation-era performance did not persist as a stable operational property after deployment. Calibration drift emerged consistently and often preceded detectable changes in discrimination. Workflow-associated changes in data availability and timing were more strongly and consistently associated with degradation than population-level indicators. Label-independent operational signals, including input missingness and data latency, provided early indication of emerging fragility, whereas outcome-based monitoring was delayed by label latency and documentation processes. These findings suggest that post-deployment fragility can be a structural property of clinical AI systems embedded in evolving workflows. Effective governance therefore requires lifecycle-oriented monitoring strategies that combine calibration reassessment with operational telemetry throughout deployment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.